UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cyclin E as a potential therapeutic target in high grade serous ovarian cancer

Gynecologic oncology, 2016-10, Vol.143 (1), p.152-158

2016

Volltextzugriff (PDF)

Indole-3-carbinol synergistically sensitises ovarian cancer cells to bortezomib treatment

British journal of cancer, 2012-01, Vol.106 (2), p.333-343

2012

Volltextzugriff (PDF)

Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin

Oncogene, 2010-01, Vol.29 (1), p.26-33

2010

Volltextzugriff (PDF)

BRCA1 promoter region hypermethylation in ovarian carcinoma : A population-based study

Cancer research (Chicago, Ill.), 2000-10, Vol.60 (19), p.5329-5333

2000

Volltextzugriff (PDF)

Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy

Gynecologic oncology, 2013-05, Vol.129 (2), p.364-371

2013

Volltextzugriff (PDF)

Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer

Gynecologic oncology, 2023-03, Vol.170, p.221-228

2023

Volltextzugriff (PDF)

Survival Impact of Surgical Cytoreduction in Stage IV Epithelial Ovarian Cancer

Gynecologic oncology, 1999-03, Vol.72 (3), p.278-287

1999

Volltextzugriff (PDF)

Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer

Gynecologic oncology, 2021-12, Vol.163 (3), p.465-472

2021

Volltextzugriff (PDF)

Differential gene expression between normal and tumor-derived Ovarian epithelial cells

Cancer research (Chicago, Ill.), 2000-12, Vol.60 (23), p.6744-6749

2000

Volltextzugriff (PDF)

Hormone receptor expression in uterine sarcomas: Prognostic and therapeutic roles

Gynecologic oncology, 2009-12, Vol.115 (3), p.466-471

2009

Volltextzugriff (PDF)

Improved survival in women with BRCA‐associated ovarian carcinoma

Cancer, 2003-05, Vol.97 (9), p.2187-2195

2003

Volltextzugriff (PDF)

FIGO stage III and IV uterine papillary serous carcinoma: Impact of residual disease on survival

International journal of gynecological cancer, 2002-09, Vol.12 (5), p.454-458

2002

Volltextzugriff (PDF)

Foxc2 induces Wnt4 and Bmp4 expression during muscle regeneration and osteogenesis

Cell death and differentiation, 2013-08, Vol.20 (8), p.1031-1042

2013

Volltextzugriff (PDF)

Vaginal high-grade sarcoma in pregnancy

Gynecologic oncology reports, 2021-11, Vol.38, p.100881, Article 100881

2021

Volltextzugriff (PDF)

Ovulation induction, infertility, and ovarian cancer risk

Fertility and sterility, 1996-10, Vol.66 (4), p.499-507

1996

Volltextzugriff (PDF)

Overexpression of AKT2/Protein Kinase B beta Leads to Up-Regulation of beta 1 Integrins, Increased Invasion, and Metastasis of Human Breast and Ovarian Cancer Cells

Cancer research (Chicago, Ill.), 2003-01, Vol.63 (1), p.196-206

2003

Volltextzugriff (PDF)

Whole-Body Positron Emission Tomography with 2-[ 18F]-Fluoro-2-deoxy-D-glucose Can Detect Recurrent Ovarian Carcinoma

Gynecologic oncology, 1993-11, Vol.51 (2), p.175-181

1993

Volltextzugriff (PDF)

Comparative hybridization of an array of 21 500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas

Gene, 1999-10, Vol.238 (2), p.375-385

1999

Volltextzugriff (PDF)

Altered expression of transforming growth factor‐β ligands and receptors in primary and recurrent ovarian carcinoma

Cancer, 1999-02, Vol.85 (3), p.658-668

1999

Volltextzugriff (PDF)

Secondary surgical cytoreduction for advanced epithelial ovarian cancer: Patient selection and review of the literature

Cancer, 1996-11, Vol.78 (10), p.2049-2062

1996

Volltextzugriff (PDF)

Primary Ovarian Cancer Cultures are Resistant to Fas-Mediated Apoptosis

Gynecologic oncology, 1999-08, Vol.74 (2), p.265-271

1999

Volltextzugriff (PDF)

HER-2/neu, p53, and DNA analyses as prognosticators for survival in endometrial carcinoma

Obstetrics and gynecology (New York. 1953), 1995-05, Vol.85 (5 Pt 1), p.729-734

1995

Volltextzugriff (PDF)

Molecular similarities between primary peritoneal and primary ovarian carcinomas

International journal of gynecological cancer, 2003-11, Vol.13 (6), p.749-755

2003

Volltextzugriff (PDF)

Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor β growth arrest independent of transforming growth factor β/Smad signaling

Cancer research (Chicago, Ill.), 2003-03, Vol.63 (6), p.1413-1419

2003

Volltextzugriff (PDF)

A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer

Cancer gene therapy, 2002-07, Vol.9 (7), p.553-566

2002

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(131)
Mit Volltextzugriff
(124)

Publikationsform

Sprache

Englisch
(137)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cyclin E as a potential therapeutic target in high grade serous ovarian cancer

Indole-3-carbinol synergistically sensitises ovarian cancer cells to bortezomib treatment

Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin

BRCA1 promoter region hypermethylation in ovarian carcinoma : A population-based study

Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy

Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer

Survival Impact of Surgical Cytoreduction in Stage IV Epithelial Ovarian Cancer

Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer

Differential gene expression between normal and tumor-derived Ovarian epithelial cells

Hormone receptor expression in uterine sarcomas: Prognostic and therapeutic roles

Improved survival in women with BRCA‐associated ovarian carcinoma

FIGO stage III and IV uterine papillary serous carcinoma: Impact of residual disease on survival

Foxc2 induces Wnt4 and Bmp4 expression during muscle regeneration and osteogenesis

Vaginal high-grade sarcoma in pregnancy

Ovulation induction, infertility, and ovarian cancer risk

Overexpression of AKT2/Protein Kinase B beta Leads to Up-Regulation of beta 1 Integrins, Increased Invasion, and Metastasis of Human Breast and Ovarian Cancer Cells

Whole-Body Positron Emission Tomography with 2-[ 18F]-Fluoro-2-deoxy-D-glucose Can Detect Recurrent Ovarian Carcinoma

Comparative hybridization of an array of 21 500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas

Altered expression of transforming growth factor‐β ligands and receptors in primary and recurrent ovarian carcinoma

Secondary surgical cytoreduction for advanced epithelial ovarian cancer: Patient selection and review of the literature

Primary Ovarian Cancer Cultures are Resistant to Fas-Mediated Apoptosis

HER-2/neu, p53, and DNA analyses as prognosticators for survival in endometrial carcinoma

Molecular similarities between primary peritoneal and primary ovarian carcinomas

Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor β growth arrest independent of transforming growth factor β/Smad signaling

A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer

Suchergebnisse filtern